ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 8.97
(-0.44%)
CNY 8.97
(-0.44%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.87 Billion CNY | 8.88% |
| 2022 | 6.29 Billion CNY | 29.18% |
| 2021 | 4.87 Billion CNY | 24.55% |
| 2020 | 3.91 Billion CNY | 19.84% |
| 2019 | 3.26 Billion CNY | 6.59% |
| 2018 | 3.06 Billion CNY | 10.51% |
| 2017 | 2.77 Billion CNY | 29.49% |
| 2016 | 2.14 Billion CNY | 68.89% |
| 2015 | 1.26 Billion CNY | 5.01% |
| 2014 | 1.2 Billion CNY | 1.77% |
| 2013 | 1.18 Billion CNY | 24.69% |
| 2012 | 951.32 Million CNY | -11.19% |
| 2011 | 1.07 Billion CNY | 83.41% |
| 2010 | 584.06 Million CNY | 41.07% |
| 2009 | 414.02 Million CNY | 29.56% |
| 2008 | 319.56 Million CNY | 109.59% |
| 2007 | 152.46 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.75 Billion CNY | 1.46% |
| 2024 Q1 | 1.72 Billion CNY | 1.83% |
| 2024 Q3 | 1.73 Billion CNY | -1.09% |
| 2023 Q4 | 1.69 Billion CNY | 13.1% |
| 2023 FY | 6.85 Billion CNY | 8.88% |
| 2023 Q1 | 1.81 Billion CNY | 21.23% |
| 2023 Q2 | 1.85 Billion CNY | 1.81% |
| 2023 Q3 | 1.5 Billion CNY | -18.92% |
| 2022 Q2 | 1.64 Billion CNY | 3.64% |
| 2022 Q3 | 1.56 Billion CNY | -4.47% |
| 2022 Q4 | 1.49 Billion CNY | -4.43% |
| 2022 FY | 6.29 Billion CNY | 29.18% |
| 2022 Q1 | 1.58 Billion CNY | -5.03% |
| 2021 Q4 | 1.66 Billion CNY | 50.89% |
| 2021 FY | 4.87 Billion CNY | 24.55% |
| 2021 Q1 | 1.01 Billion CNY | -16.02% |
| 2021 Q2 | 1.08 Billion CNY | 7.44% |
| 2021 Q3 | 1.1 Billion CNY | 1.71% |
| 2020 Q2 | 1.08 Billion CNY | 47.73% |
| 2020 Q1 | 737.08 Million CNY | -23.15% |
| 2020 Q3 | 882.03 Million CNY | -19.0% |
| 2020 FY | 3.91 Billion CNY | 19.84% |
| 2020 Q4 | 1.2 Billion CNY | 36.61% |
| 2019 Q3 | 695.65 Million CNY | -22.41% |
| 2019 FY | 3.26 Billion CNY | 6.59% |
| 2019 Q1 | 713.93 Million CNY | -22.42% |
| 2019 Q2 | 896.53 Million CNY | 25.58% |
| 2019 Q4 | 959.1 Million CNY | 37.87% |
| 2018 FY | 3.06 Billion CNY | 10.51% |
| 2018 Q4 | 920.29 Million CNY | 8.63% |
| 2018 Q3 | 847.19 Million CNY | 28.87% |
| 2018 Q2 | 657.42 Million CNY | 2.96% |
| 2018 Q1 | 638.53 Million CNY | -2.61% |
| 2017 Q4 | 655.63 Million CNY | -20.72% |
| 2017 Q2 | 686.07 Million CNY | 13.69% |
| 2017 Q1 | 603.45 Million CNY | -9.01% |
| 2017 FY | 2.77 Billion CNY | 29.49% |
| 2017 Q3 | 826.97 Million CNY | 20.54% |
| 2016 Q3 | 431.72 Million CNY | -23.01% |
| 2016 FY | 2.14 Billion CNY | 68.89% |
| 2016 Q1 | 485.12 Million CNY | 39.88% |
| 2016 Q2 | 560.75 Million CNY | 15.59% |
| 2016 Q4 | 663.23 Million CNY | 53.62% |
| 2015 Q1 | 278.54 Million CNY | -14.22% |
| 2015 FY | 1.26 Billion CNY | 5.01% |
| 2015 Q2 | 398.96 Million CNY | 43.23% |
| 2015 Q3 | 243.31 Million CNY | -39.01% |
| 2015 Q4 | 346.8 Million CNY | 42.54% |
| 2014 Q3 | 284.37 Million CNY | -10.5% |
| 2014 Q4 | 324.73 Million CNY | 14.19% |
| 2014 FY | 1.2 Billion CNY | 1.77% |
| 2014 Q1 | 280.34 Million CNY | -21.14% |
| 2014 Q2 | 317.72 Million CNY | 13.33% |
| 2013 Q4 | 355.51 Million CNY | 61.12% |
| 2013 Q2 | 274.07 Million CNY | -18.43% |
| 2013 Q1 | 335.99 Million CNY | 21.61% |
| 2013 FY | 1.18 Billion CNY | 24.69% |
| 2013 Q3 | 220.65 Million CNY | -19.49% |
| 2012 Q3 | 185.53 Million CNY | -19.89% |
| 2012 Q1 | 257.9 Million CNY | -5.89% |
| 2012 Q4 | 276.28 Million CNY | 48.91% |
| 2012 FY | 951.32 Million CNY | -11.19% |
| 2012 Q2 | 231.59 Million CNY | -10.2% |
| 2011 Q1 | 304.7 Million CNY | 72.53% |
| 2011 FY | 1.07 Billion CNY | 83.41% |
| 2011 Q4 | 274.03 Million CNY | 2.63% |
| 2011 Q3 | 267 Million CNY | 18.4% |
| 2011 Q2 | 225.51 Million CNY | -25.99% |
| 2010 FY | 584.06 Million CNY | 41.07% |
| 2010 Q2 | 125.49 Million CNY | -11.3% |
| 2010 Q3 | 140.47 Million CNY | 11.94% |
| 2010 Q4 | 176.6 Million CNY | 25.72% |
| 2010 Q1 | 141.48 Million CNY | 45.43% |
| 2009 FY | 414.02 Million CNY | 29.56% |
| 2009 Q3 | 88.8 Million CNY | 0.0% |
| 2009 Q4 | 97.28 Million CNY | 9.55% |
| 2008 FY | 319.56 Million CNY | 109.59% |
| 2007 FY | 152.46 Million CNY | 0.0% |